These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 30132546

  • 21. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 06; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 23. Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy.
    Okabayashi Y, Tsuboi N, Haruhara K, Kanzaki G, Koike K, Shimizu A, Miyazaki Y, Ohno I, Kawamura T, Ogura M, Yokoo T.
    Clin Exp Nephrol; 2016 Dec 06; 20(6):910-917. PubMed ID: 26830548
    [Abstract] [Full Text] [Related]

  • 24. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
    Woo KT, Lau YK, Wong KS, Chiang GS.
    Kidney Int; 2000 Dec 06; 58(6):2485-91. PubMed ID: 11115082
    [Abstract] [Full Text] [Related]

  • 25. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan 06; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 26. Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria.
    Pei G, Tan J, Tang Y, Tan L, Zhong Z, Zhou L, Chen C, Qin W.
    Medicine (Baltimore); 2020 Jun 12; 99(24):e20513. PubMed ID: 32541473
    [Abstract] [Full Text] [Related]

  • 27. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 12; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 28. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Visciano B, Pani A, De Silvestri A, De Simone I, Del Vecchio L, Terraneo V, Furiani S, Santagostino G, Corghi E, Pozzi C.
    PLoS One; 2016 Sep 12; 11(7):e0158584. PubMed ID: 27416024
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
    Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ, Lv JC, Zhang H.
    BMC Nephrol; 2019 Aug 05; 20(1):297. PubMed ID: 31382914
    [Abstract] [Full Text] [Related]

  • 30. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Aug 05; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 31. Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.
    Watanabe-Kusunoki K, Nakazawa D, Yamamoto J, Matsuoka N, Kaneshima N, Nakagaki T, Yamamoto R, Maoka T, Iwasaki S, Tsuji T, Fukasawa Y, Nishimoto N, Nishio S, Atsumi T.
    Medicine (Baltimore); 2021 Dec 17; 100(50):e27778. PubMed ID: 34918629
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH.
    J Nephrol; 2016 Aug 17; 29(4):567-73. PubMed ID: 26537358
    [Abstract] [Full Text] [Related]

  • 33. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P, Shi SF, Qu Z, Zhao N, Xie XF, Lv JC, Liu LJ, Zhang H.
    Ren Fail; 2018 Nov 17; 40(1):213-218. PubMed ID: 29619862
    [Abstract] [Full Text] [Related]

  • 34. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study.
    Wang J, Juan C, Huang Q, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2013 Sep 17; 28(9):2339-45. PubMed ID: 23787555
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin II local hyperreactivity in the progression of IgA nephropathy.
    Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi PG.
    Am J Kidney Dis; 1993 Jun 17; 21(6):593-602. PubMed ID: 8503412
    [Abstract] [Full Text] [Related]

  • 36. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1.
    Bi X, Yu Y, Zhou S, Zhou Y, Zhao J, Xiong J.
    Nephron; 2024 Jun 17; 148(9):587-600. PubMed ID: 38723614
    [Abstract] [Full Text] [Related]

  • 37. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 38. Are children with IgA nephropathy different from adult patients?
    Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H.
    Pediatr Nephrol; 2024 Aug 18; 39(8):2403-2412. PubMed ID: 38578470
    [Abstract] [Full Text] [Related]

  • 39. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb 18; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 40. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.
    Cheng J, Zhang W, Zhang XH, He Q, Tao XJ, Chen JH.
    Int J Clin Pract; 2009 Jun 18; 63(6):880-8. PubMed ID: 19490198
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.